This form of inflammatory bowel disease (IBD) has symptoms similar to other conditions, which can make diagnosis problematic.

Many patients with IBD report persisting symptoms ... When symptoms persist after resolution of inflammation, other GI ...

Several studies suggest that diet plays a vital role in the etiopathogenesis of Crohn’s disease. Experts share their insights ...

Alcohol can worsen Crohn’s disease symptoms, but the impact varies from person to person. It may depend on what and how much ...

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...

Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, ...

Direct costs associated with IBD include ambulatory visits to gastroenterologists, emergency department visits, admissions ...

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients involves trial and error during the treatment process.

A randomized controlled trial finds no clear benefit of adding bezlotoxumab to FMT in patients with IBD and recurrent C difficile infection.

HERLEV, Denmark, Nov. 11, 2024 /PRNewswire/ -- Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE ...

Constipation may occur in Crohn’s disease, but research suggests it’s more common in ulcerative colitis, the other type of IBD. What is the best laxative for someone with Crohn’s disease?

The use of glucagon-like peptide 1 (GLP-1) agonists in patients with inflammatory bowel disease (IBD) was associated with few ...